[REVISION HISTORY]

Huawei expands wearable lineup and HarmonyOS ecosystem

Updated 66 times since CLSTR started tracking revisions of this situation.

What changed

2026-10-25 14:25 UTC → 2026-10-26 19:49 UTC · added ~~removed~~

Huawei continues to expand its wearable lineup and HarmonyOS ecosystem, maintaining a global wrist-worn market share of over 20 percent as of the first half of 2026. The company has held the top position in the Chinese wrist-worn market since 2021 and has frequently led the global market since 2024. In late September 2026, Huawei executed a global rollout of the Watch GT 7 Series, including the standard models and the premium Watch GT 7 Pro. The series features the HUAWEI TruSense system, the Sunflower positioning system, and battery life lasting up to 21 days. The Pro model utilizes a titanium alloy frame, nano-tech ceramic bezel, and sapphire glass. Recent updates highlight the series' focus on data interpretation through features like ‘Physical Readiness’, ‘Morning Briefing’, and ‘Celia AI Health Insights’. Regional integrations include support for the 7-Eleven app in Thailand and a partnership with LinkAja in Indonesia to enable QRIS digital payments via the smartwatch. In October 2026, Huawei expanded the availability of the Watch GT 7 series to Brazil and Saudi Arabia. ~~In Saudi Arabia,~~ Recent product expansions include the ~~series utilizes research from~~ introduction of the ~~Saudi-Chinese Joint Laboratory for Cardiovascular Diseases~~ Huawei Band 10, which features a 1.47-inch AMOLED display, HarmonyOS 4.0, and ~~Dubai Health~~ up to ~~provide proactive wellness assessments~~ 14 days of battery life, alongside the Watch 6, which offers eSIM connectivity for ~~coronary heart disease~~ smartphone-independent calls and ~~diabetes.~~ notifications. The company is also ~~introduced a sapphire glass version of~~ advancing its medical-grade technology with the HUAWEI WATCH ~~FIT 4 in Japan, featuring an 8.2-inch AMOLED display and 2,000 nits of brightness. The Watch D3, a medical-grade smartwatch~~ D3. Designed for 24-hour ambulatory blood pressure monitoring (ABPM), the device is ~~being deployed globally in markets including Chile, Peru,~~ the ~~Philippines, Mexico,~~ first wrist-worn wearable to meet ISO standards for accurate blood pressure measurement both before and ~~Egypt. The device uses~~ after physical activity. Utilizing a mechanical airbag ~~system~~ integrated into the ~~strap and~~ strap, the Watch D3 has received CE Medical Device certification ~~in the European Union.~~ for resting, ambulatory, and pre- and post-exercise monitoring. To support medical research, Huawei established the Wearable Blood Pressure Technology Innovation Fund in collaboration with the International Society of Hypertension.

Versions

Only revisions since CLSTR began indexing content versions appear here. Showing the 50 most recent. Select a version to see what changed compared to the one before it.